Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NADROPARIN Cause Cutaneous vasculitis? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Cutaneous vasculitis have been filed in association with NADROPARIN. This represents 0.7% of all adverse event reports for NADROPARIN.

5
Reports of Cutaneous vasculitis with NADROPARIN
0.7%
of all NADROPARIN reports
0
Deaths
5
Hospitalizations

How Dangerous Is Cutaneous vasculitis From NADROPARIN?

Of the 5 reports, 5 (100.0%) required hospitalization.

Is Cutaneous vasculitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NADROPARIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does NADROPARIN Cause?

Foetal exposure during pregnancy (81) Off label use (77) Premature baby (73) Maternal exposure during pregnancy (72) Drug ineffective (54) Sepsis (46) Dyspnoea (44) Fall (43) Exposure during pregnancy (42) Confusional state (40)

What Other Drugs Cause Cutaneous vasculitis?

METHOTREXATE (207) ADALIMUMAB (193) TOCILIZUMAB (161) ETANERCEPT (148) APIXABAN (131) HYDROXYCHLOROQUINE (125) LEFLUNOMIDE (116) ABATACEPT (112) ANAKINRA (112) INFLIXIMAB (108)

Which NADROPARIN Alternatives Have Lower Cutaneous vasculitis Risk?

NADROPARIN vs NAFARELIN NADROPARIN vs NAFCILLIN NADROPARIN vs NAFCILLIN\NAFCILLIN NADROPARIN vs NAFRONYL NADROPARIN vs NAFTIFINE

Related Pages

NADROPARIN Full Profile All Cutaneous vasculitis Reports All Drugs Causing Cutaneous vasculitis NADROPARIN Demographics